Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy
Background: Radiotherapy plays an important role for symptom control in advanced stage cancer patients. Yet patients need to be carefully selected, and its use and benefits must be weighed against time spent under treatment and patient priorities in the last phase of life. In this study, we assess p...
Main Authors: | Sebastian M. Christ, Markus Schettle, Annina Seiler, Matthias Guckenberger, David Blum, Nicolaus Andratschke, Caroline Hertler |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Clinical and Translational Radiation Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405630821000653 |
Similar Items
-
Palliative radiotherapy near the end of life
by: Susan Y. Wu, et al.
Published: (2019-03-01) -
Understanding palliative radiotherapy use for BC cancer patients at the end of life
by: Huang, Jin
Published: (2013) -
Radiotherapy for the Palliation of Advanced Sarcomas—The Effectiveness of Radiotherapy in Providing Symptomatic Improvement for Advanced Sarcomas in a Single Centre Cohort
by: Hannah Tween, et al.
Published: (2019-10-01) -
Palliative Radiotherapy to Asymptomatic Bone Metastasis: Is It Beneficial or Not? Single Institution Experience
by: Shoukri Elazab, et al.
Published: (2021-07-01) -
End of Life Experience of Symptom Cluster and Their Management in Hong Kong Chinese Patients with Lung Cancer Who Receive Palliative Radiotherapy
by: Y.Y. CHUI, et al.
Published: (2009-05-01)